Novo Nordisk Initiates Multi-Billion Share Buyback
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
J&J, Roche Come Out on Top in S&P Ratings of Strongest Pharma Companies
Trending Stocks This Week as U.S. Equities Notch Their Best Week of 2024
The Trader: Medtronic Stock Has Hit Been by Anti-Obesity Concerns. Why It Should Rebound. -- Barron's
Doctors Struggle to Secure Medicare Coverage for Heart Patients on Novo Nordisk's Wegovy
Novo Nordisk to Build $221M Plant to Manufacture Drug Raw Materials
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
Sector Update: Health Care Stocks Rise in Afternoon Trading
Medicare Negotiates Lower Prices for 10 High-cost Drugs
Unpacking the Latest Options Trading Trends in Novo Nordisk
Novo Nordisk Goes Ex Dividend Tomorrow
Big Pharma: The Government Revealed Its List of Negotiated Drug Prices. Here Are the Reactions.
Novo Nordisk Appeals Ruling on CMS' Drug Price Negotiation Program
Medicare's New Drug Prices Are Out. They Aren't So Bad for Drugmakers -- Barrons.com
Negotiations on pharmaceutical prices in the United States have resulted in significant price reductions for ten key medications with the highest reduction approaching 80%.
According to the inflation reduction bill of the Biden administration, the final negotiated prices of the top 10 pharmaceuticals in Part D of federal medical insurance have been determined and announced.
Biden Administration Releases Prices of 10 Drugs in Medicare Negotiations
U.S. Announces Final Drug Prices After Medicare Negotiations
U.S. Government Targets $6B in Saving From First Medicare Drug Price Negotiations
Medtronic Stock Has Hit Been by Anti-Obesity Concerns. Why It Should Rebound. -- Barrons.com